Las pautas para el examen de patentabilidad de las solicitudes de patentes de invenciones químico-farmacéuticas de Argentina. Efectos a largo plazo en la actividad inventiva y adaptación al ADPIC
- ISSN: 1139-3289
- Revista: ACTAS DE DERECHO INDUSTRIAL Y DERECHO DE AUTOR
- Número: 37
- Fecha de publicación: 1 de Enero de 2017
- Nº Pág.: 22
Producto en formato electrónico.
6,00 €
In 2012 Argentina issued new Guidelines for the Patentability Examination of Patent Applications for Chemical and Pharmaceutical Inventions, whose intent seems to grant patents only
on new molecules, and not on inventions relating to already existing molecules. The main goal of these Guidelines is to improve access to drugs. The article considers that, although the problem of access to drugs is worth any effort, the Argentine Guidelines could result in decreased investments in research for incremental innovations, and reduce the flow of new drugs. The last part of this article deals with the problem of the consistency of the Argentine Guidelines with the TRIPs Agreement, showing that it is possible to doubt said consistency.
.
